Health Discoveries in General Health News

CRT-D heart treatment found to benefit women most

February 8, 2011
A study on heart patients in the U.S., Canada and Europe found that cardiac sysynchronization therapy with defibrillator (CRT-D) is twice as effective in preventing heart failure in women than in men.

According to the February issue of the Journal of the American College of Cardiology, CRT-D combines the work of an implantable cardioverter defibrillator (ICD), which prevents sudden, irregular rhythm cardiac death, with resynchronization therapy, which strengthens heart function and reduces the risk of heart failure.

The study on more than 1,800 patients found that CRT-D reduced heart failure by 70 percent, compared to a 35 reduction in men.

The types of heart disease generally experienced by women, including non-ischemic heart disease marked by inflammatory scarring of the heart muscle, are more receptive to treatment by CRT-D, the study stated.

In the U.S., CRT-D is approved to treat patients who have experienced severe heart failure, as well as those who have had milder heart failure to help prevent their condition from becoming severe.

Thomson Reuters ranks North Shore University Hospital in Manhasset, New York, among the top 100 hospitals for cardiovascular care, the only New York hospital to make the list among teaching hospitals with cardiovascular residency programs. The hospital is part of the North Shore-LIJ Health System.
  • Bookmark this Page
  • Toggle Text Size
  • Print this Page
Search CRT-D heart treatment found to benefit women most: